Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Theranostics · 25.02.2025 · 15 (8) · 3551-3570
DOI: 10.7150/thno.108691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 25.02.2025. Verfasst von Siqi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Drug Delivery Systems, Diabetes Complications, Eye Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China.
Zitieren
APA
Wang, S., Yang, H., Zheng, J., Tong, A., Mu, S., Wang, D., Zhao, M., & Li, J. (2025). Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications. Theranostics, 15(8), 3551-3570. https://doi.org/10.7150/thno.108691
Vancouver
Wang S, Yang H, Zheng J, Tong A, Mu S, Wang D, et al. Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications. Theranostics. 2025;15(8):3551-3570. doi:10.7150/thno.108691
BibTeX
@article{Wang2025,
author = {Wang, Siqi and Yang, Hongyu and Zheng, Jiaying and Tong, Aiyang and Mu, Sen and Wang, Dongkai and Zhao, Ming and Li, Ji},
title = {Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {8},
pages = {3551--3570},
doi = {10.7150/thno.108691}
}
EUVIMED